Event is featuring:

Click in to view our esteemed speakers’ Biography

Keynote Speaker

Panelists

Moderators

Mentors

Full line up of speakers will be updated soon, do come back to check it out!

Professor Mangala Srinivas

Professor Mangala Srinivas

Professor of Cell Biology and Immunology, Wageningen University & Research (WUR);
Member of the Group of Chief Scientific Advisors to the European Commission

Mangala Srinivas is Professor of Cell Biology and Immunology at Wageningen University & Research (WUR), where she served as Head of Department until 2025. She earned an accelerated B.Sc. (Hons.) at the National University of Singapore and a PhD at Carnegie Mellon University (USA). Before joining WUR, she worked at GE Healthcare, developing a global imaging strategy, and led a research group at Radboud University Medical Center. She also co-founded the spin-off Cenya Imaging B.V., serving as CSO.

Her research focuses on nanotechnology for various in vivo applications. She pioneered the use of 19F MRI for quantitative cell tracking and now develops customisable nanoparticles for imaging and immunomodulation, including oxygen-delivery systems. Produced at GMP grade, these agents will soon advance to a first-in-human clinical trial through an EIC Transition project she coordinates. Her team integrates MRI, PET, SPECT, ultrasound, fluorescence, and photoacoustic imaging. This work has been supported through ERC, NWO VENI, ERA-NET, H2020, EIC, and Venture Challenge funding. In brief, her career bridges industry and academia, and she will be taking a nanotechnology-based imaging agent from development in a lab to clinical application.

Mangala is deeply engaged in science policy and leadership. As former Chair of the Young Academy of Europe, she championed Open Science, diversity, and fair recognition in academia, and continues to serve on the Scientific Advisory Board of Open Research Europe. She has delivered over 70 invited lectures worldwide, and has served on evaluation panels for the EC, NWO, and international agencies.

In 2025, she was appointed to the Group of Chief Scientific Advisors to the European Commission, part of the Scientific Advice Mechanism (SAM), becoming the first scientist from WUR and only the third from the Netherlands to hold this role. The SAM provides evidence-based policy advice at the highest level of the European Commission.

Outside science, she finds balance and perspective in raising her three young children, and seriously misses Singaporean makan.

Professor Ivy Ng

Professor Ivy Ng

Singapore Health Services Pte Ltd
Senior Advisor, SingHealth Board

Professor Ivy Ng is Senior Advisor, SingHealth Board. From 2012 to 2024, she was Group Chief Executive Officer, SingHealth, Singapore’s largest public healthcare group, comprising 3 Acute Hospitals, 1 Specialist Hospital, 5 National Specialty Centres (Cancer, Eye, Neurosciences, Dental and Heart), 2 Community Hospitals, 9 polyclinics, and the upcoming Eastern General Hospital.

She was inducted into the Singapore Women’s Hall of Fame in 2025 by Singapore Council of Women’s Organisations (SCWO). She has been conferred the National Day Award Public Administration Medal (Gold)(Bar) 2024, President’s Science & Technology Medal 2021, National University of Singapore (NUS) University Outstanding Service Award 2020, NTUC May Day Medal of Commendation (Gold) Award 2020. She chairs the SingHealth Fund and KKH Fund Committees, Deputy Chair of Precision Health Research Singapore (PRECISE) Board Oversight Committee and sits on the Boards of SGH Fund Committee, Duke-NUS Medical School, Singapore Management University, Temasek Trust, Temasek Foundation and National Research Foundation Singapore.

She graduated from NUS Medicine. She is a Fellow of the Royal College of Physicians (FRCP, Edinburgh), Royal College of Paediatrics and Child Health (FRCPCH, London) and Academy of Medicine, Singapore (FAMS). She is Clinical Professor, Duke-NUS Medical School and Yong Loo Lin School of Medicine, NUS.
Prof. Loh Xian Jun

Professor Loh Xian Jun

Executive Director,
A*STAR Institute of Materials Research & Engineering ( A*STAR IMRE )

Professor Loh Xian Jun is a Singaporean polymer chemist who serves as the Executive Director of A*STAR's Institute of Materials Research and Engineering (IMRE). He is globally recognized as a leading expert in the field of biodegradable thermogels and supramolecular biomaterials, which have diverse applications in drug delivery, tissue engineering, cosmetics, personal care, and the food sector. In addition to his leadership at IMRE, Prof. Loh holds concurrent Adjunct Professorships at Nanyang Technological University (NTU) and the National University ofSingapore (NUS).

His pioneering research on thermogels, which self-assemble in response to body warmth, was recognized as one of the IUPAC Top 10 Emerging Technologies in Chemistry in 2025. His innovations extend to developing "anti-cancer smart 'bombs'" for targeted therapy, inventing customizable fabric-like power sources for wearable electronics, and co-inventing a smart mask for remote vital sign monitoring during the COVID-19 pandemic. Prof. Loh is also highly active in commercialization; he co-founded the spin-off company Vitreogel Innovations to develop thermogels for retinal regeneration and has licensed technologies to companies like the Ikeda Group and Est.Lab.

An exceptionally prolific and influential scientist, Prof. Loh has authored over 500 publications, holds 38 patents, and has amassed over 46,000 citations with an H-index of 115. He is consistently named a Highly Cited Researcher by Clarivate Analytics. He earned both his B.Appl.Sc (First Class Hons) in Applied Chemistry and his Ph.D. in Bioengineering from the National University of Singapore. He was later a Visiting Fellow at the University of Cambridge and was elected a Fellow of Fitzwilliam College, Cambridge, in 2011. His significant contributions have been recognized with numerous honors, including election as a Fellow of the Singapore National Academy of Science, the Royal Society of Chemistry, the Institute of Materials, Minerals & Mining, and The Institution of Engineering and Technology. In 2022, he received the Singapore Public Administration Service National Award (Silver) for his contributions during the COVID-19 pandemic.

Assoc. Prof. Valerie Chew

Associate Professor Valerie Chew

Principal Investigator
Translational Immunology Institute (TII), SingHealth Duke-NUS
Associate Professor, Duke-NUS Medical School

Assoc Prof. Valerie Chew, PhD, Translational Immunology Institute (TII), Singapore, is a Principal Investigator at TII and Associate Professor at Duke-NUS Medical School, Singapore. A key opinion leader in liver cancer immunology, Dr. Chew's research focuses on elucidating the complex and diverse immune contexture within the tumor microenvironment of patients with hepatocellular carcinoma (HCC). She leverages advanced single-cell and spatial technologies including CyTOF, single-cell RNA sequencing, and spatial transcriptomics, to perform multi-dimensional immune profiling and identify clinically relevant biomarkers and therapeutic targets. Dr. Chew serves as Associate Editor for the Journal of Hepatology and Clinical and Molecular Hepatology, and is an advisory board member for Nature Reviews Gastroenterology & Hepatology. She is also the Treasurer and a Governing Board Member of the International Liver Cancer Association (ILCA), where she contributes to global efforts in liver cancer research, education, and policy development.

Adrian Teo

Assistant Professor Adrian Teo

Senior Principal Investigator, Division Director, Director of Graduate Affairs Institute of Molecular and Cell Biology (IMCB), A*Star
Associate Professor, Department of Biochemistry, Yong Loo Lin School of Medicine, NUS

A/P Adrian TEO obtained his B.Sc. (1st Class) from the National University of Singapore (NUS). He completed his Ph.D. on stem cell biology with Prof Ludovic Vallier at the University of Cambridge, under an A*STAR Scholarship. Concurrently, he was also an Honorary Cambridge Commonwealth Trust Scholar. He then trained with Prof Rohit Kulkarni at Joslin Diabetes Center, Harvard Medical School, as a Juvenile Diabetes Research Foundation (JDRF) fellow, on pancreatic islet biology and diabetes.

Adrian is currently a Senior Principal Investigator at the Institute of Molecular and Cell Biology (IMCB), A*STAR; Division Director of the Cellular Engineering and Therapy (CET) Division; Division Director of the Biomolecular Engineering and Technologies (BET) Division at IMCB, A*STAR; a tenured Associate Professor at Yong Loo Lin School of Medicine, National University of Singapore; and Director of Graduate Affairs (DGA) of the Biomedical Research Council (BMRC), A*STAR. His laboratory uses human pluripotent stem cells for disease modelling of diabetes, developing therapeutics and cell therapy. He is also a co-founder of BetaLife Pte Ltd focused on the use of stem cell therapy for diabetes patients. He is a member of the Oxbridge Society of Singapore, the International Society for Stem Cell Research (ISSCR) and an EXCO member/Vice-Secretary of the Stem Cell Society Singapore (SCSS).

Assoc. Prof. Angela Chow

Associate Professor Angela Chow

Senior Consultant
Tan Tock Seng Hospital, NHG Health; LKCMedicine NTU; Saw Swee Hock School of Public Health, NUS

Assoc. Prof. Angela Chow is the Clinical Director of the Office of Clinical Epidemiology, Analytics, and kNowledge (OCEAN) and Senior Consultant at the Department of Epidemiology and Preventive Medicine, at Tan Tock Seng Hospital. She also holds joint and adjunct appointments as Associate Professor at the Lee Kong Chian School of Medicine and Saw Swee Hock School of Public Health respectively.

Angela graduated in Medicine from the National University of Singapore, was trained as a Public Health specialist, and obtained a PhD in Epidemiology at the University of California, Los Angeles. Prior to joining Tan Tock Seng Hospital, Angela had assumed various positions at the Ministry of Health Singapore where she developed national communicable disease surveillance systems and strategies, influenza pandemic preparedness plans, health services development programmes and non-communicable disease interventions.

Angela oversees the socio-behavioural epidemiology and programme and outcomes evaluation services at Tan Tock Seng Hospital. She is also involved with the epidemiological surveillance and prevention and control of healthcare-associated infections and emerging infectious diseases. Angela is a clinician-scientist who is passionate about translating evidence to improving patient care and population health. Her research interests include antimicrobial resistance and stewardship, infection prevention and control, infectious disease surveillance and epidemiology, implementation science, and population health. Over the years, her SteWARdS (Steering towards the Wise use of AntimicRobials through understanding & addressing the determinants in Singapore) research group has harnessed quantitative and qualitative mixed methods to elucidate socio-behavioural factors influencing antibiotic use and preventive health behaviours to inform practices and policies to improve clinical and health outcomes.

Muhammad Raihan Jumat

Asst. Prof. Muhammad Raihan Jumat PhD, FHEA

Assistant Professor, Medical Education
Duke-NUS Medical School

Muhammad Raihan Jumat is an educationalist and programme lead with experience at the intersection of translational medicine, healthcare innovation, and education. He currently serves as an Assistant Professor at Duke-NUS Medical School, where he is closely involved in the design, delivery, and coordination of postgraduate programmes in translational medicine, including the Master of International Translational Medicine (MITM) and the Graduate Certificate in International Translational Medicine (GC-ITM).

Raihan plays a key role in teaching and coordinating courses focused on commercialization, entrepreneurship, health equity, research methods, and innovation within the translational medicine pathway. His work emphasizes bridging the gap between scientific discovery and real-world impact, with a strong focus on unmet medical needs, stakeholder alignment, and the practical realities of translating healthcare innovations from bench to bedside. He regularly collaborates with clinicians, scientists, industry partners, investors, and regulators to provide learners with authentic, multi-stakeholder perspectives.

Raihan’s teaching philosophy centers on constructivist learning with a strong emphasis on empowering learners with the necessary knowledge, skills and attitudes which are needed in their respective domains.

Raihan is actively involved in curriculum development, educational research, and programme innovation, with interests in competency-based education, reflective practice, and the use of technology to enhance learning. Across all his roles, he is committed to cultivating thoughtful, resilient, and impact-driven practitioners who can translate ideas into meaningful outcomes for patients and society.